Dana-Farber/Harvard Cancer Center Continuing Umbrella of Research Experiences (CURE) Program
The Continuing Umbrella of Research Experiences (CURE) Program is a full-time, paid, rigorous 7-11 week summer research internship for students interested in pursuing a career in scientific research. Through engagement in mentored summer cancer research projects, scientific and professional skills training, and networking and social events, students will acquire scientific knowledge and technical skills and increase their understanding of how to conduct biomedical research.
Program Features:
- Hands-on, Cutting Edge Cancer Research
- Mentorship from Leading Scientists
- Summer Stipends
- Scientific Skills Training
- Research Seminars
- Journal Club
- Social Events
- Career Exploration
- Professional Development
- Abstracts and Presentations
- Present at and attend conferences
- Networking
Location(s)
- Dana-Farber/Harvard Cancer Center, Boston, Massachusetts
Schedule
- High school students: June 18th, 2025
- College students: May 27th, 2025
Cost/Compensation
- Interns will be paid a weekly stipend that is determined by funding sources that vary from year to year
Eligibility Requirements
- Be a high school sophomore, junior, or senior or a college freshman, sophomore, or junior
- Be 16 years old at the start of the program
- Reside in and/or attend school in Massachusetts and be able to travel to the Longwood Medical Area in Boston five days a week in the summer
Deadline
- February 3rd, 2025
Application or Entry Requirements
- Completion of an application form
- Copy of transcript or report card from most current school and year
- Current resume
- TWO Letter(s) of Recommendation (maximum of three; one of these letters must be from a science or mathematics teacher/professor)
Notifications of Decisions
Financial Aid Details
Other Dates to Keep in Mind
Have other questions?
Dana-Farber/Harvard Cancer Center was founded to integrate and build upon the collective talent and resources of the Harvard cancer research community. Five Boston academic medical institutions—Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital—and two Harvard Schools—the Harvard Medical School and the Harvard T.H. Chan School of Public Health—combined their scientific strengths to create a rich, collaborative environment that transcends institutional borders. DF/HCC is the powerful successor organization to the Dana-Farber Cancer Institute Comprehensive Cancer Center, one of the original cancer centers designated by the NCI in 1973.
